Return to work after breast cancer diagnosis: An observational prospective study of 125 patients in South America (2017)
- Authors:
- Autor USP: MANO, MAX SENNA - FM
- Unidade: FM
- DOI: 10.1158/1538-7445.SABCS16-P4-19-06
- Subjects: ESTUDOS PROSPECTIVOS; NEOPLASIAS MAMÁRIAS; AMÉRICA DO SUL
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Cancer Research
- ISSN: 0008-5472
- Volume/Número/Paginação/Ano: v. 77, n. 4, suppl., abst. P4-19-06, 2017
- Conference titles: AACR Special Conference on Translational Control of Cancer: A New Frontier in Cancer Biology and Therapy
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
LANDEIRO, L. G. et al. Return to work after breast cancer diagnosis: An observational prospective study of 125 patients in South America. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.SABCS16-P4-19-06. Acesso em: 19 abr. 2024. , 2017 -
APA
Landeiro, L. G., Fraile, N. M. P., Fede, A. B., Fonseca, L. G., Testa, L., Petry, V., et al. (2017). Return to work after breast cancer diagnosis: An observational prospective study of 125 patients in South America. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. doi:10.1158/1538-7445.SABCS16-P4-19-06 -
NLM
Landeiro LG, Fraile NMP, Fede AB, Fonseca LG, Testa L, Petry V, Gonçalves MS, Costa RDP, Cohn DB, Ferrari MM, Sunahara RS, Gouveia ACC de, Mano MS. Return to work after breast cancer diagnosis: An observational prospective study of 125 patients in South America [Internet]. Cancer Research. 2017 ; 77( 4):[citado 2024 abr. 19 ] Available from: https://doi.org/10.1158/1538-7445.SABCS16-P4-19-06 -
Vancouver
Landeiro LG, Fraile NMP, Fede AB, Fonseca LG, Testa L, Petry V, Gonçalves MS, Costa RDP, Cohn DB, Ferrari MM, Sunahara RS, Gouveia ACC de, Mano MS. Return to work after breast cancer diagnosis: An observational prospective study of 125 patients in South America [Internet]. Cancer Research. 2017 ; 77( 4):[citado 2024 abr. 19 ] Available from: https://doi.org/10.1158/1538-7445.SABCS16-P4-19-06 - Value of systemic staging in asymptomatic early breast cancer
- Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
- Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1
- Reply to [Carta]: mastectomy skin flap thickness
- O uso do Oncotype DX® na indicação de quimioterapia adjuvante - experiência do Hospital Sírio-Libanês
- Pneumonite não-infecciosa em paciente com tumor neuroendócrino tratado com everolimus (EVR)
- Multidisciplinary international survey of post-operative radiation therapy practices after nipple-sparing or skin-sparing mastectomy
- A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)
- HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials
- Rare tumors research in emerging countries
Informações sobre o DOI: 10.1158/1538-7445.SABCS16-P4-19-06 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
